Overview

PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST)

Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
This is a pilot study, phase III, multi-centre, double blind, randomized controlled trial of patients with traumatic brain injury (TBI).
Phase:
Phase 3
Details
Lead Sponsor:
Sunnybrook Health Sciences Centre
Collaborators:
Canadian Institutes of Health Research (CIHR)
Sunnybrook Research Institute
Treatments:
Anticoagulants
Dalteparin
Heparin, Low-Molecular-Weight
Tinzaparin